Roka Bioscience Prices IPO At $12/shr - Quick Facts

(RTTNews) - Roka Bioscience Inc., a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, announced the pricing of its initial public offering of 5 million shares of its common stock at a public offering price of $12.00 per share, before underwriting discounts. All of the common stock is being offered by Roka Bioscience.

In addition, Roka Bioscience noted that it has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares of common stock at the initial public offering price.

The shares are expected to begin trading on the NASDAQ Global Market on July 17, 2014 under the ticker symbol "ROKA".

The offering is expected to close on July 22, 2014, subject to customary closing conditions.